JACC: Case Reports (May 2020)

A Novel Variant in APOB Gene Causes Extremely Low LDL-C Without Known Adverse Effects

  • Ida Surakka, PhD,
  • Whitney E. Hornsby, PhD,
  • Linda Farhat, MS,
  • Melvyn Rubenfire, MD,
  • Lars G. Fritsche, PhD,
  • Kristian Hveem, MD, PhD,
  • Y. Eugene Chen, MD, PhD,
  • Robert D. Brook, MD,
  • Cristen J. Willer, PhD,
  • Richard L. Weinberg, MD, PhD

Journal volume & issue
Vol. 2, no. 5
pp. 775 – 779

Abstract

Read online

A novel frameshift variant was identified in APOB that segregates in a dominant manner with low levels of low-density lipoprotein cholesterol. Affected family members show no apparent clinical complications. There is no consensus regarding clinical management, and the long-term consequences of low levels of low-density lipoprotein cholesterol remain unknown. (Level of Difficulty: Advanced.)

Keywords